NSETrading Window26 Jun 2026 · 26 Jun 2026, 03:40 pm

Trading Window

Gaudium IVF and Women Health Limited · GAUDIUMIVF

✦ AI SummaryResults

Gaudium IVF and Women Health Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015, ahead of the announcement of unaudited standalone and consolidated financial results for the quarter ending June 30, 2026.

Analysis Scores

Earnings Impact0/10
Growth Catalyst0/10
Governance Concern0/10
Regulatory Risk0/10
Balance Sheet Risk0/10
Liquidity Impact0/10
Market Sentiment0/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Gaudium IVF and Women Health Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015

Attachments (1)

📄

GAUDIUM_26062026153952_Q1_June_2026_Trading_Window_Closure.pdf

pdf

Download →
View document text
gaudium® IVF Delivering Motherhood Dreams June 26, 2026 BSE Limited National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers, Exchange Plaza, C-1, Block G, Bandra Dalal Street, Fort, Kurla Complex, Bandra (E), Mumbai — Mumbai — 400001 400051 Serip Code — 544709 Symbol - GAUDIUMIVF ISIN: INEOP8B01020 ISIN: INEOP8B01020 Subject: Intimation for Closure of Trading Window Dear Sir/Ma’am, This is to inform you that in compliance with the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015, including amendments, if any, and as per the Company’s “Code of conduct to regulate, monitor and report trading by Designated Persons and their immediate relatives ("Code”) and Code of practices and procedures for fair disclosure of unpublished price sensitive information (“Fair Disclosure Code”), the trading window for dealing in the securities of the Company shall remain closed for the designated persons and their immediate relatives from Wednesday, July 01, 2026 till the expiry of 48 (forty eight) hours after the announcement of unaudited standalone and consolidated financial results of the Company for the quarter ending June 30, 2026. The date of the meeting of the Board of Directors of the Company inter alia, to approve the financial results of the Company for the aforesaid period will be intimated separately in due course of time. The above is for information and records. Thanking you, Yours faithfully, For and on behalf of Gaudium IVF and Women Health Limited (Formerly Known as Gaudium IVF and Women Health Private Limited) Naveen Kumar Company Secretary and Compliance Officer Membership No: A69788 Gaudium IVF and Women Health Limited (Formerly known as Gaudium IVF and Women Health Pvt. Ltd.) Registered Office : B1/51, Janakpuri, New Delhi- 110058 | Ph: 011-4885 8585 CIN : L85100DL2015PLC278296 Email : info@gaudiumivfcentre.com Website : www.gaudiumivfcentre.com [El#